These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 12717860)
41. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells. Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139 [TBL] [Abstract][Full Text] [Related]
42. Three novel mutations of the CIITA gene in MHC class II-deficient patients with a severe immunodeficiency. Dziembowska M; Fondaneche MC; Vedrenne J; Barbieri G; Wiszniewski W; Picard C; Cant AJ; Steimle V; Charron D; Alca-Loridan C; Fischer A; Lisowska-Grospierre B Immunogenetics; 2002 Feb; 53(10-11):821-9. PubMed ID: 11862382 [TBL] [Abstract][Full Text] [Related]
43. Isoforms of the class II transactivator protein. Barbieri G; Deffrennes V; Prod'homme T; Vedrenne J; Baton F; Cortes C; Fischer A; Bono MR; Lisowska-Grospierre B; Charron D; Alcaïde-Loridan C Int Immunol; 2002 Aug; 14(8):839-48. PubMed ID: 12147620 [TBL] [Abstract][Full Text] [Related]
44. Mapping RNA-protein interactions in ribonuclease P from Escherichia coli using disulfide-linked EDTA-Fe. Biswas R; Ledman DW; Fox RO; Altman S; Gopalan V J Mol Biol; 2000 Feb; 296(1):19-31. PubMed ID: 10656815 [TBL] [Abstract][Full Text] [Related]
45. Persistence of MHC DR nonexpression on swine cells by introduction of a mutated MHC class II transactivator gene: a comparison with the effect induced by antisense RNA. Ou Q; Lin L; Huang L; Chen F; Wu K; Lu P; Zhang J; Chou KY J Clin Immunol; 2004 Jan; 24(1):97-106. PubMed ID: 14997039 [TBL] [Abstract][Full Text] [Related]
46. γ-Interferon-regulated chaperone governs human lymphocyte antigen class II expression. Kämper N; Franken S; Temme S; Koch S; Bieber T; Koch N FASEB J; 2012 Jan; 26(1):104-16. PubMed ID: 21940994 [TBL] [Abstract][Full Text] [Related]
47. Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma. Piskurich JF; Gilbert CA; Ashley BD; Zhao M; Chen H; Wu J; Bolick SC; Wright KL Mol Immunol; 2006 Feb; 43(6):519-28. PubMed ID: 15950283 [TBL] [Abstract][Full Text] [Related]
48. The major histocompatibility complex class II transactivator is differentially regulated by interferon-gamma and transforming growth factor-beta in microglial cells. Pazmany T; Tomasi TB J Neuroimmunol; 2006 Mar; 172(1-2):18-26. PubMed ID: 16360884 [TBL] [Abstract][Full Text] [Related]
49. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain. Itoh-Lindstrom Y; Piskurich JF; Felix NJ; Wang Y; Brickey WJ; Platt JL; Koller BH; Ting JP J Immunol; 1999 Sep; 163(5):2425-31. PubMed ID: 10452977 [TBL] [Abstract][Full Text] [Related]
50. Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA. Geirsson A; Paliwal I; Lynch RJ; Bothwell AL; Hammond GL Transplantation; 2003 Jul; 76(2):387-94. PubMed ID: 12883198 [TBL] [Abstract][Full Text] [Related]
51. Class II transactivator (CIITA) promoter methylation does not correlate with silencing of CIITA transcription in trophoblasts. Holtz R; Choi JC; Petroff MG; Piskurich JF; Murphy SP Biol Reprod; 2003 Sep; 69(3):915-24. PubMed ID: 12748124 [TBL] [Abstract][Full Text] [Related]
52. Major histocompatibility class II HLA-DR alpha gene expression in thyrocytes: counter regulation by the class II transactivator and the thyroid Y box protein. Montani V; Taniguchi SI; Shong M; Suzuki K; Ohmori M; Giuliani C; Napolitano G; Saji M; Fiorentino B; Reimold AM; Ting JP; Kohn LD; Singer DS Endocrinology; 1998 Jan; 139(1):280-9. PubMed ID: 9421426 [TBL] [Abstract][Full Text] [Related]
53. The MHC class II transactivator (CIITA) mRNA stability is critical for the HLA class II gene expression in myelomonocytic cells. De Lerma Barbaro A; Procopio FA; Mortara L; Tosi G; Accolla RS Eur J Immunol; 2005 Feb; 35(2):603-11. PubMed ID: 15627980 [TBL] [Abstract][Full Text] [Related]
54. [Expression of major histocompatibility complex class II antigens on lungs in rat with bleomycin-induced pulmonary fibrosis]. Ni LF; Zhang ZG; Bu DF; Liu XM Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):514-8. PubMed ID: 18931716 [TBL] [Abstract][Full Text] [Related]
56. RNase P ribozymes selected in vitro to cleave a viral mRNA effectively inhibit its expression in cell culture. Kilani AF; Trang P; Jo S; Hsu A; Kim J; Nepomuceno E; Liou K; Liu F J Biol Chem; 2000 Apr; 275(14):10611-22. PubMed ID: 10744757 [TBL] [Abstract][Full Text] [Related]
57. Acquisition of novel catalytic activity by the M1 RNA ribozyme: the cost of molecular adaptation. Cole KB; Dorit RL J Mol Biol; 1999 Oct; 292(4):931-44. PubMed ID: 10525416 [TBL] [Abstract][Full Text] [Related]
58. A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites. Arancibia-Cárcamo CV; Osawa H; Arnett HA; Háskova Z; George AJ; Ono SJ; Ting JP; Streilein JW Eur J Immunol; 2004 Feb; 34(2):471-80. PubMed ID: 14768052 [TBL] [Abstract][Full Text] [Related]
59. Cleavage by RNase P of gene N mRNA reduces bacteriophage lambda burst size. Li Y; Altman S Nucleic Acids Res; 1996 Mar; 24(5):835-42. PubMed ID: 8600449 [TBL] [Abstract][Full Text] [Related]
60. Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-gamma in haematopoietic tumour cells. Morimoto Y; Toyota M; Satoh A; Murai M; Mita H; Suzuki H; Takamura Y; Ikeda H; Ishida T; Sato N; Tokino T; Imai K Br J Cancer; 2004 Feb; 90(4):844-52. PubMed ID: 14970863 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]